Y Intercept Hong Kong Ltd acquired a new stake in shares of Humana Inc. (NYSE:HUM – Free Report) in the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm acquired 6,229 shares of the insurance provider’s stock, valued at approximately $1,523,000.
A number of other institutional investors and hedge funds have also bought and sold shares of HUM. Cary Street Partners Investment Advisory LLC increased its stake in Humana by 63.9% during the 1st quarter. Cary Street Partners Investment Advisory LLC now owns 118 shares of the insurance provider’s stock valued at $31,000 after purchasing an additional 46 shares in the last quarter. Zions Bancorporation National Association UT bought a new stake in Humana during the 1st quarter valued at about $37,000. CVA Family Office LLC increased its stake in Humana by 63.4% during the 2nd quarter. CVA Family Office LLC now owns 219 shares of the insurance provider’s stock valued at $54,000 after purchasing an additional 85 shares in the last quarter. Ransom Advisory Ltd bought a new stake in Humana during the 1st quarter valued at about $66,000. Finally, Transamerica Financial Advisors LLC grew its stake in shares of Humana by 1,027.6% in the first quarter. Transamerica Financial Advisors LLC now owns 327 shares of the insurance provider’s stock worth $87,000 after acquiring an additional 298 shares during the period. 92.38% of the stock is currently owned by institutional investors.
Humana Stock Performance
Shares of NYSE HUM opened at $278.02 on Monday. The firm has a 50 day moving average of $281.34 and a 200 day moving average of $258.62. The company has a current ratio of 1.95, a quick ratio of 1.95 and a debt-to-equity ratio of 0.69. The firm has a market capitalization of $33.44 billion, a price-to-earnings ratio of 21.34, a price-to-earnings-growth ratio of 1.71 and a beta of 0.42. Humana Inc. has a 12-month low of $206.87 and a 12-month high of $315.35.
Humana Announces Dividend
Wall Street Analysts Forecast Growth
A number of analysts have recently commented on the stock. Bank of America lifted their price target on shares of Humana from $280.00 to $300.00 and gave the stock a “neutral” rating in a research note on Friday, October 10th. Wolfe Research lifted their price target on shares of Humana from $283.00 to $313.00 and gave the stock an “outperform” rating in a research note on Monday, October 6th. Evercore ISI assumed coverage on shares of Humana in a research note on Monday, September 22nd. They issued an “in-line” rating and a $295.00 price target for the company. Truist Financial set a $300.00 price target on shares of Humana in a research note on Tuesday, October 14th. Finally, Morgan Stanley reduced their price target on shares of Humana from $290.00 to $277.00 and set an “equal weight” rating for the company in a research note on Thursday, July 31st. Eight analysts have rated the stock with a Buy rating, ten have issued a Hold rating and two have assigned a Sell rating to the company. According to MarketBeat.com, the stock currently has a consensus rating of “Hold” and an average price target of $297.58.
Read Our Latest Analysis on Humana
Humana Profile
Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.
Read More
- Five stocks we like better than Humana
- How to Choose Top Rated Stocks
- Is Lemonade Stock Set for a Big Squeeze After Earnings?
- Golden Cross Stocks: Pattern, Examples and Charts
- Caterpillar Stock Could Top $650 by Year’s End
- What is MarketRank™? How to Use it
- ServiceNow’s 5-for-1 Split Is a Signal for Investors to Buy
Want to see what other hedge funds are holding HUM? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Humana Inc. (NYSE:HUM – Free Report).
Receive News & Ratings for Humana Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Humana and related companies with MarketBeat.com's FREE daily email newsletter.
